L-Asparaginase Suppliers & Bulk Manufacturers

Available Forms: IV Infusion and IV/ IM Injection

Available Strengths: 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion)

Reference Brands: Elspar® , Asparlas®, Erwinase® (US & EU)

Category: Oncology Cancer Care

L-asparaginase is available in IV Infusion and IV/ IM Injection and strengths such as 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, L-asparaginase is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

L-asparaginase can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: L-asparaginase is an essential enzyme-based chemotherapy used in the treatment of acute lymphoblastic leukemia (ALL) and lymphomas. It works by depleting asparagine, an amino acid needed for cancer cell survival. Available under brands like Elspar®, Asparlas®, and Erwinase®, it is offered in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via intravenous (IV) or intramuscular (IM) injection, L-asparaginase is widely sourced by B2B pharmaceutical wholesalers in the US and EU. These therapies ensure reliable GMP-compliant distribution for oncology centers, offering competitive pricing and consistent supply for cancer treatment.